MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2021.766400

Медицинская библиотека · Frontiers in medicine · 2021

Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis.

Ren Danfeng, Cao Wenya, Liu Xiaojing, Han Qunying, Fan Wanhu, Li Guoliang, Xia Han, Zhang Xi

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Background

No consensus has been reached regarding the optimal therapy for visceral leishmaniasis (VL), which affects ~12 million people worldwide. Case Presentation: This report described four cases of VL encountered in the First Affiliated Hospital of Xi'an Jiaotong University between October 2019 and December 2020. Of the four patients, one patient experienced relapse after antimonial treatment, and the remaining patients had primary VL (including one patient with impaired kidney function and one patient with hemophagocytic syndrome). All patients received a novel treatment protocol, namely the low-dose L-AmB therapy, which was characterized by a low initial dose, cautious dose escalation, and low-dose therapy as maintenance. All patients were cured without severe complications, and there was no further recurrence during follow-up.

Conclusions

This case series demonstrated the safety and efficacy of the low-dose L-AmB therapy for VL patients, providing novel treatment protocol for the VL.

Для цитирования: Ren Danfeng, Cao Wenya, Liu Xiaojing, Han Qunying, Fan Wanhu, Li Guoliang, Xia Han, Zhang Xi. Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis.. Frontiers in medicine. 2021. DOI: 10.3389/fmed.2021.766400.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.